Shire plc (LSE: SHP, NASDAQ: SHPG), (the “Company”) announces that on March 28, 2013 Ordinary Shares (“Shares”) and American Depository Shares (“ADSs”) of the Company, as set out below, had been acquired for the Non-Executive Directors, being the part of their total fees that are paid in shares for the period of service from January 1 to March 31, 2013.
|Type of Security(1)||Number of Shares/ADSs|
|Dr. Steven Gillis||ADSs||80|
|Dr. David Ginsburg||ADSs||73|
(1) One ADS is equal to three Shares
The Shares and ADSs were acquired on the London Stock Exchange and NASDAQ respectively, at prices of £19.90 per Share and $90.00 per ADS.
This notification relates to disclosures made in accordance with 3.1.4(R)(1)(a) of the Disclosure and Transparency Rules.
Deputy Company Secretary
For further information please contact:
+1 781 482 0999
+44 1256 894157
Notes to editors
Shire enables people with life-altering conditions to lead better lives.
Through our deep understanding of patients’ needs, we develop and provide healthcare in the areas of:
as well as other symptomatic conditions treated by specialist physicians.
We aspire to imagine and lead the future of healthcare, creating value for patients, physicians, policymakers, payors and our shareholders.
Click here for the PDF version of this press release.